Get access to our best features
Get access to our best features
Published 8 months ago

Molnupiravir: COVID drug linked to mutations that could 'spread the illness', scientists say

  • A study has found that the antiviral drug molnupiravir can cause mutations in the COVID-19 virus, potentially leading to further infection and genetic diversity in the surviving viral population.
  • These mutations were more likely in older age groups, which aligns with the use of antiviral treatment in higher-risk individuals.
  • The findings of the study have raised questions about the overall benefits and risks of molnupiravir and similar drugs, urging regulators to consider the possibility of persistent antiviral-induced mutations when developing new treatments.
Insights by Ground AI
Does this summary seem wrong?

0 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 61% of the sources are Center
61% Center

To view factuality data please Upgrade to Premium


To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)